Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Song-Bai Cai
Institution:
Nanjing IASO Biotechnology Co., Ltd. (China)
Observed institutions:
Tongji Hospital,
Nanjing IASO Biotechnology Co., Ltd. (China),
Huazhong University of Science and Technology
ORCID:
0009-0009-2457-2058
Observed ORCID:
0009-0009-2457-2058
OpenAlex ID:
A5013744595
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results
2023
·
Chuan Qin
, Dai-Shi Tian
, et al.
·
Signal Transduction and Targeted Therapy
·
175
PDF
Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy
2024
·
Chuan Qin
, Ming-Hao Dong
, et al.
·
Proceedings of the National Academy of Sciences
·
84
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis
2024
·
Dai-Shi Tian
, Chuan Qin
, et al.
·
EMBO Molecular Medicine
·
73
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
2024
·
Chuan Qin
, Min Zhang
, et al.
·
Science Immunology
·
66
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis
2025
·
Chuan Qin
, Ming-Hao Dong
, et al.
·
Cell
·
46
Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy
2025
·
Ming-Hao Dong
, Zhi-Cheng Mei
, et al.
·
Med
·
21
PDF
Show more works
View as search
Works count:
6
Citation count:
465
H-index:
6
I10-index:
6
Year
Topic
Type
